Page last updated: 2024-08-23

captopril and fluorodeoxyglucose f18

captopril has been researched along with fluorodeoxyglucose f18 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kondo, K; Nagata, M; Nakaya, K; Otani, T; Otsuka, H	1

Other Studies

1 other study(ies) available for captopril and fluorodeoxyglucose f18

Article	Year
Tumor growth-inhibitory effect of an angiotensin-converting enzyme inhibitor (captopril) in a lung cancer xenograft model analyzed using 18F-FDG-PET/CT. Nuclear medicine communications, 2016, Volume: 37, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Mice; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays	2016

Article

Year

Tumor growth-inhibitory effect of an angiotensin-converting enzyme inhibitor (captopril) in a lung cancer xenograft model analyzed using 18F-FDG-PET/CT.

Nuclear medicine communications, 2016, Volume: 37, Issue:2

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Mice; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays

2016